The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability
Open Access
Abstract
Mutations in BRCA1 result in predisposal to breast and ovarian cancers, but many variants exist with unknown clinical significance (VUS). One is BRCA1 c.4096+3A>G, which affects production of the full-length BRCA1 transcript, while augmenting transcripts lacking most or all of exon 11. Nonetheless, homozygosity of this variant has been reported in a healthy woman. We saw this variant cosegregate with breast and ovarian cancer in several family branches of four Icelandic pedigrees, with instances of phenocopies and a homozygous woman with lung cancer. We found eight heterozygous carriers (0.44%) in 1820 unselected breast cancer cases, and three (0.15%) in 1968 controls (p = 0.13). Seeking conclusive evidence, we studied tumors from carriers in the pedigrees for wild-type-loss of heterozygosity (wtLOH) and BRCA1-characteristic prevalence of estrogen receptor (ER) negativity. Of 15 breast and six ovarian tumors, wtLOH occurred in nine breast and all six ovarian tumours, and six of the nine breast tumors with wtLOH were ER-negative. These data accord with a pathogenic BRCA1-mutation. Our findings add to the current knowledge of BRCA1, and the role of its exon 11 in cancer pathogenicity, and will be of use in clinical genetic counselling.Keywords
Funding Information
- Landspitali University Hospital Research Fund (A-2019-001)
- The Icelandic association "Walking for Breast Cancer Research" (Göngum saman) ((no number))
This publication has 73 references indexed in Scilit:
- BRCA1 and Its Network of Interacting PartnersBiology, 2013
- ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genesHuman Mutation, 2011
- Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteinsJournal of Cellular Physiology, 2011
- Characterization ofBRCA1andBRCA2deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE studyHuman Mutation, 2010
- Genetic evidence and integration of various data sources for classifying uncertain variants into a single modelHuman Mutation, 2008
- Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significanceHuman Mutation, 2008
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test resultsHuman Mutation, 2008
- Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancerInternational Journal of Cancer, 2002
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971